In turn, IgA concentration was significantly higher in the COVID-19 pneumonia group than the ambulatory group, and a high concentration in the acute phase of COVID-19 increased the risk of pneumonia 3.4-fold42. This evidence concerns the gene CD79A and susceptibility to pneumonia measurement.